22.09.2022
Petrovax Pharm won the 1C contest

On September 15, the 1C:Project of the Year Organizing Committee summed up the results of the sixth corporate automation contest on the 1C:Enterprise 8 platform. Petrovax became the winner of the 1C:Project of the Year contest for the successful transition to the 1С:ERP system.

1С is one of the most famous companies on the Russian market, it specializes in the development and support of computer programs that help automate business. The 1C:Project of the Year contest is held for the sixth time to determine advanced users and partners who have achieved the greatest success in the digitalization and implementation of 1C:Enterprise 8 solutions.

More than 280 applications were submitted for the contest, of which 217 projects were qualified.

The “Digital Transformation of Petrovax, Pharmaceutical Market Leader, Based on Modern 1C:ERP system” project won in the category "The best project in the subject area”. For the company, the transition to a new system means improved tools for faster decision-making, systematization and optimization of resource expenses, both within the routine, and for further business development.

The project that secured the company’s victory was implemented by a team of highly qualified professionals for 15 months. Thanks to the leading IT staff, the transition to a new system was carried out in the shortest possible time and on the first try.

The success of the Petrovax team was highly appreciated by the jury comprising of management representatives of large enterprises and industry associations. Read more about how the ERP system was implemented in the interview with Alexander Rybakov, Head of Business Solutions Development and Support at Petrovax Pharm: How to create an unified enterprise automation platform | Executive.ru (e-xecutive.ru)nbsp;| Executive.ru (e-xecutive.ru).

The list of winning projects by category is published at https://eawards.1c.ru/winners/.


Back to the list

© Petrovax
The materials posted on the site are for informational purposes only and are not intended to advertise or promote the manufacturer or medications produced.